393 related articles for article (PubMed ID: 17548076)
21. The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome--a randomised, double-blind, placebo-controlled trial.
Lord J; Thomas R; Fox B; Acharya U; Wilkin T
BJOG; 2006 Jul; 113(7):817-24. PubMed ID: 16827766
[TBL] [Abstract][Full Text] [Related]
22. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome.
Wu Y; Zhang J; Wen Y; Wang H; Zhang M; Cianflone K
Fertil Steril; 2009 Jan; 91(1):213-9. PubMed ID: 18206145
[TBL] [Abstract][Full Text] [Related]
23. Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment.
Jakubowska J; Bohdanowicz-Pawlak A; Milewicz A; Szymczak J; Bednarek-Tupikowska G; Demissie M
Gynecol Endocrinol; 2008 Jul; 24(7):378-84. PubMed ID: 18645710
[TBL] [Abstract][Full Text] [Related]
24. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
Maciel GA; Soares Júnior JM; Alves da Motta EL; Abi Haidar M; de Lima GR; Baracat EC
Fertil Steril; 2004 Feb; 81(2):355-60. PubMed ID: 14967373
[TBL] [Abstract][Full Text] [Related]
25. Metformin in the treatment of clomiphene citrate-resistant women with polycystic ovary syndrome undergoing in vitro fertilisation treatment: a randomised controlled trial.
Qublan HS; Al-Khaderei S; Abu-Salem AN; Al-Zpoon A; Al-Khateeb M; Al-Ibrahim N; Megdadi M; Al-Ahmad N
J Obstet Gynaecol; 2009 Oct; 29(7):651-5. PubMed ID: 19757275
[TBL] [Abstract][Full Text] [Related]
26. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.
Nafiye Y; Sevtap K; Muammer D; Emre O; Senol K; Leyla M
Fertil Steril; 2010 Apr; 93(6):1864-9. PubMed ID: 19171332
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effect of metformin on pregnancy outcome in women with polycystic ovary syndrome is not associated with major changes in C-reactive protein levels or indices of coagulation.
Vanky E; Salvesen KA; Hjorth-Hansen H; Bjerve K; Carlsen SM
Fertil Steril; 2006 Mar; 85(3):770-4. PubMed ID: 16500361
[TBL] [Abstract][Full Text] [Related]
28. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment.
An Y; Sun Z; Zhang Y; Liu B; Guan Y; Lu M
Clin Endocrinol (Oxf); 2014 Mar; 80(3):425-31. PubMed ID: 23869585
[TBL] [Abstract][Full Text] [Related]
29. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome.
Schoyer KD; Liu HC; Witkin S; Rosenwaks Z; Spandorfer SD
Fertil Steril; 2007 Jul; 88(1):139-44. PubMed ID: 17320874
[TBL] [Abstract][Full Text] [Related]
30. Impact of Metformin on IVF Outcomes in Overweight and Obese Women With Polycystic Ovary Syndrome: A Randomized Double-Blind Controlled Trial.
Abdalmageed OS; Farghaly TA; Abdelaleem AA; Abdelmagied AE; Ali MK; Abbas AM
Reprod Sci; 2019 Oct; 26(10):1336-1342. PubMed ID: 29576001
[TBL] [Abstract][Full Text] [Related]
31. Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment.
Fleming R; Harborne L; MacLaughlin DT; Ling D; Norman J; Sattar N; Seifer DB
Fertil Steril; 2005 Jan; 83(1):130-6. PubMed ID: 15652898
[TBL] [Abstract][Full Text] [Related]
32. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
Palomba S; Falbo A; Orio F; Manguso F; Russo T; Tolino A; Annamaria C; Dale B; Zullo F
Hum Reprod; 2005 Oct; 20(10):2879-86. PubMed ID: 15958399
[TBL] [Abstract][Full Text] [Related]
33. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
[TBL] [Abstract][Full Text] [Related]
34. Do women with ovaries of polycystic morphology without any other features of PCOS benefit from short-term metformin co-treatment during IVF? A double-blind, placebo-controlled, randomized trial.
Swanton A; Lighten A; Granne I; McVeigh E; Lavery S; Trew G; Talmor A; Raine-Fenning N; Jayaprakasan K; Child T
Hum Reprod; 2011 Aug; 26(8):2178-84. PubMed ID: 21593045
[TBL] [Abstract][Full Text] [Related]
35. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
[TBL] [Abstract][Full Text] [Related]
36. Effects of pioglitazone on ovarian stromal blood flow, ovarian stimulation, and in vitro fertilization outcome in patients with polycystic ovary syndrome.
Kim CH; Jeon GH; Kim SR; Kim SH; Chae HD; Kang BM
Fertil Steril; 2010 Jun; 94(1):236-41. PubMed ID: 19324344
[TBL] [Abstract][Full Text] [Related]
37. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
[TBL] [Abstract][Full Text] [Related]
38. Use of metformin in polycystic ovary syndrome.
Mathur R; Alexander CJ; Yano J; Trivax B; Azziz R
Am J Obstet Gynecol; 2008 Dec; 199(6):596-609. PubMed ID: 19084097
[TBL] [Abstract][Full Text] [Related]
39. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
40. Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovary syndrome. A prospective comparative study.
Qublan HS; Yannakoula EK; Al-Qudah MA; El-Uri FI
Saudi Med J; 2007 Nov; 28(11):1694-9. PubMed ID: 17965792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
